Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients

被引：0
|
作者：
Marta Reina-Couto
Mariana Roboredo-Madeira
Patrícia Pereira-Terra
Carolina Silva-Pereira
Sandra Martins
Luísa Teixeira-Santos
Dora Pinho
Andreia Dias
Gonçalo Cordeiro
Cláudia Camila Dias
António Sarmento
Margarida Tavares
João T. Guimarães
Roberto Roncon-Albuquerque
José-Artur Paiva
António Albino-Teixeira
Teresa Sousa
机构：
[1] Faculdade de Medicina da Universidade do Porto (FMUP),Departamento de Biomedicina
[2] Centro de Investigação Farmacológica e Inovação Medicamentosa da Universidade do Porto (MEDInUP),Unidade de Farmacologia e Terapêutica
[3] Centro Hospitalar Universitário de São João (CHUSJ),Serviço de Medicina Intensiva
[4] CHUSJ,Serviço de Farmacologia Clínica
[5] CHUSJ,Serviço de Patologia Clínica
[6] FMUP,Departamento de Medicina da Comunidade, Informação e Decisão em Saúde
[7] CINTESIS-Centro de Investigação em Tecnologias e Serviços de Saúde,Serviço de Doenças Infecciosas
[8] CHUSJ,Departamento de Medicina
[9] FMUP,EPIUnit
[10] Instituto de Saúde Pública da Universidade do Porto,Departamento de Biomedicina
[11] FMUP,Unidade de Bioquímica
[12] FMUP,Departamento de Cirurgia e Fisiologia
来源：
Inflammation Research | 2023年 / 72卷
关键词：
Urinary cysteinyl leukotrienes; COVID-19; Disease severity; Veno-venous extracorporeal membrane oxygenation (VV-ECMO); Outcomes; Comorbidities;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 491
页数：16
相关论文
共 50 条
  • [31] Mast cells: Therapeutic targets for COVID-19 and beyond
    Lam, Hiu Yan
    Tergaonkar, Vinay
    Kumar, Alan Prem
    Ahn, Kwang Seok
    IUBMB LIFE, 2021, 73 (11) : 1278 - 1292
  • [32] COVID-19 associated complications and potential therapeutic targets
    Monpara, Jasmin D.
    Sodha, Srushti J.
    Gupta, Pardeep K.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 886
  • [33] Therapeutic targets and potential agents for the treatment of COVID-19
    Wu, Yinuo
    Li, Zhe
    Zhao, Yun-Song
    Huang, Yi-You
    Jiang, Mei-Yan
    Luo, Hai-Bin
    MEDICINAL RESEARCH REVIEWS, 2021, 41 (03) : 1775 - 1797
  • [34] Severity of COVID-19 infection in patients with COVID-19 combined with diabetes
    Lu, Dan
    Liu, Yuhong
    Ma, Pengcheng
    Hou, Rui
    Wang, Jin
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2024, 43 (01)
  • [35] Symptom Spectrum and the Evaluation of Severity and Duration of Symptoms in Patients with COVID-19
    Dane, Senol
    Akyuz, Murat
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2021, 9 (08): : 262 - 266
  • [36] COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention
    Sharma, Jiten R.
    Yadav, Umesh C. S.
    OBESITY RESEARCH & CLINICAL PRACTICE, 2021, 15 (02) : 163 - 171
  • [37] A review of COVID-19 biomarkers and drug targets: resources and tools
    Caruso, Francesca P.
    Scala, Giovanni
    Cerulo, Luigi
    Ceccarelli, Michele
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 701 - 713
  • [38] Clinical Value of Inflammatory Biomarkers in Determining Severity of COVID-19
    Gulacti, Umut
    Lok, Ugur
    Aydin, Irfan
    Turgut, Kasim
    Yavuz, Erdal
    Kaya, Hakan
    Kafadar, Huseyin
    Arslan, Ebru
    Sonmez, Cihad
    Algin, Abdullah
    Kurt, Ercan
    Ozdin, Mehmet
    Yucetas, Seyho Cem
    JOURNAL OF ACUTE MEDICINE, 2023, 13 (02) : 58 - 64
  • [39] Biomarkers of biological age as predictors of COVID-19 disease severity
    Lauc, Gordan
    Sinclair, David
    AGING-US, 2020, 12 (08): : 6490 - 6491
  • [40] Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room
    Assandri, Roberto
    Buscarini, Elisabetta
    Canetta, Ciro
    Scartabellati, Alessandro
    Vigano, Giovanni
    Montanelli, Alessandro
    ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (06) : 598 - 599
12345